Journey Medical Corp
NASDAQ:DERM 4:00:00 PM EDT
| Market Cap (Intraday) | 121.05M |
| Current PE | 143.59 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.93 |
| 50-Day MA | $5.17 |
| 200-Day MA | $4.64 |
Journey Medical Corp Stock, NASDAQ:DERM
9237 E Via de Ventura Boulevard, Suite 105, Scottsdale, Arizona 85258
United States of America
Phone: +1.480.434.6670
Number of Employees: 58
Description
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.